These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26157576)

  • 21. [Roles of Wnt signaling in bone metabolism].
    Kobayashi Y
    Clin Calcium; 2012 Nov; 22(11):1701-6. PubMed ID: 23103814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts.
    Koide M; Kobayashi Y; Yamashita T; Uehara S; Nakamura M; Hiraoka BY; Ozaki Y; Iimura T; Yasuda H; Takahashi N; Udagawa N
    J Bone Miner Res; 2017 Oct; 32(10):2074-2086. PubMed ID: 28543818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
    Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
    J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling.
    Li F; Cain JD; Tombran-Tink J; Niyibizi C
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3449-3458. PubMed ID: 30076958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sclerostin Inhibition: A Novel Target for the Treatment of Postmenopausal Osteoporosis.
    Aditya S; Rattan A
    J Midlife Health; 2021; 12(4):267-275. PubMed ID: 35264832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo analysis of Wnt signaling in bone.
    Glass DA; Karsenty G
    Endocrinology; 2007 Jun; 148(6):2630-4. PubMed ID: 17395705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
    Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
    J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
    Rossini M; Gatti D; Adami S
    Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant activation of Wnt signaling pathway altered osteocyte mineralization.
    Zhou Y; Lin J; Shao J; Zuo Q; Wang S; Wolff A; Nguyen DT; Rintoul L; Du Z; Gu Y; Peng YY; Ramshaw JAM; Long X; Xiao Y
    Bone; 2019 Oct; 127():324-333. PubMed ID: 31260814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Runx2 Controls Bone Resorption through the Down-Regulation of the Wnt Pathway in Osteoblasts.
    Haxaire C; Haÿ E; Geoffroy V
    Am J Pathol; 2016 Jun; 186(6):1598-609. PubMed ID: 27083516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin C Activates Osteoblastogenesis and Inhibits Osteoclastogenesis via Wnt/β-Catenin/ATF4 Signaling Pathways.
    Choi HK; Kim GJ; Yoo HS; Song DH; Chung KH; Lee KJ; Koo YT; An JH
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnts' fashion statement: from body stature to dysplasia.
    Malhotra D; Yang Y
    Bonekey Rep; 2014; 3():541. PubMed ID: 24991404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cajanolactone A from
    Liu S; Luo ZH; Ji GM; Guo W; Cai JZ; Fu LC; Zhou J; Hu YJ; Shen XL
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30642055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis.
    Arioka M; Takahashi-Yanaga F; Sasaki M; Yoshihara T; Morimoto S; Hirata M; Mori Y; Sasaguri T
    Biochem Pharmacol; 2014 Aug; 90(4):397-405. PubMed ID: 24955980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Regulation of Bone Metabolism and Disorders by Wnt Signaling.
    Maeda K; Kobayashi Y; Koide M; Uehara S; Okamoto M; Ishihara A; Kayama T; Saito M; Marumo K
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast.
    Frey JL; Li Z; Ellis JM; Zhang Q; Farber CR; Aja S; Wolfgang MJ; Clemens TL; Riddle RC
    Mol Cell Biol; 2015 Jun; 35(11):1979-91. PubMed ID: 25802278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt signaling control of bone cell apoptosis.
    Bodine PV
    Cell Res; 2008 Feb; 18(2):248-53. PubMed ID: 18212734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leonurine hydrochloride promotes osteogenic differentiation and increases osteoblastic bone formation in ovariectomized mice by Wnt/β-catenin pathway.
    Yang L; Liu S; Mu S; Man X; Ba G; Guo R; Li Y; Zhou L; Yang L; Fu Q
    Biochem Biophys Res Commun; 2018 Oct; 504(4):941-948. PubMed ID: 30224063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.